Revelation Capital Management, LLC — Q2 2022 13F-HR

← Revelation Capital Management, LLC

Q2 2022 · 13F-HR

Revelation Capital Management, LLCholdings as filed

Filed 2022-08-15 · accession 0000950123-22-009234

$7,067

Reported value

Positions

2022-06-30

Period end

View analyzed profile →PRO

The Brief · Revelation Capital Management, LLC · Q2 2022

AI · grounded in 13F

Revelation Capital Management, LLC established three new positions to reach a total AUM of $7,067. The fund's largest move was a $5,409 investment in SINGULAR GENOMICS SYSTEMS INC. Other new additions include NPCE at $1,228 and ACCDUSD at $430.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
82933R100	—	SINGULAR GENOMICS SYSTEMS INC	$5,409	76.5%	1,415,846	Common	SOLE
641288105	NPCE	NEUROPACE INC	$1,228	17.4%	248,127	Common	SOLE
00437E102	ACCDUSD	ACCOLADE INC	$430	6.08%	58,050	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.